Clinical trial Recruiting at 1 site Interventional Ages 21 to 85

Comparing a wearable optical blood pressure band with a traditional upper‑arm cuff for people with high blood pressure

Official title: WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control

Run by Aktiia SA · NCT07523269 · Data updated 2026-11-12

This study will test whether using the Aktiia G1 wearable blood pressure monitor helps people with high blood pressure control their blood pressure better than a traditional upper‑arm cuff.

More Hypertension (HTN) trials

Quick facts

Study typeInterventional
Ages21 Years to 85 Years
SexAll
Enrollment164 (estimated)
SponsorAktiia SA
Industry-sponsored
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedApril 2026
Main results expectedSeptember 2027
Study endsDecember 2027
Registry record updatedApril 13, 2026
Trial IDNCT07523269 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 21–85 years old with uncontrolled systolic hypertension (>135 mmHg by unattended automated office measurement), on 0–2 antihypertensive medications, who own a smartphone, can read English, have an MGB provider/EPIC record, and can attend two on‑site visits are ideal candidates.

Probably not a fit

People with severe hypertension (SBP >180 mmHg or DBP >120 mmHg), severe heart failure, advanced CKD, pregnancy, very high resting heart rate, or those without a smartphone or access to the Mass General Brigham system are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, open‑label, two‑arm randomized trial enrolling about 164 adults with uncontrolled hypertension. Participants are randomly assigned to wear an Aktiia G1 optical wrist monitor for 12 months or to use a validated upper‑arm cuff for the first 6 months and then switch to the Aktiia device for the final 6 months. The primary comparison is change in unattended automated office systolic blood pressure from baseline to 6 months, with additional data collected from device measurements and online lifestyle and health surveys. The trial is sponsored by Aktiia SA in collaboration with Mass General Brigham and conducted at Mass General Brigham sites in Boston.

Why it matters

Potential benefit: If successful, continuous wearable BP monitoring could make it easier to detect and manage uncontrolled blood pressure and improve overall BP control outside the clinic.

How similar studies have gone: Previous observational and short‑term studies of cuffless and wearable BP technologies have produced mixed results, and randomized comparisons of continuous optical monitors versus standard cuffs remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 21 to 85 years.
* Able to read and speak English.
* Have an MGB provider and medical record number in EPIC
* Study participants will wear the Aktiia bracelet for 6 months
* Willing to attend two on-site study visits and comply with all study procedures.
* Signed informed consent provided.
* Own a smartphone with iOS or Android operating system.
* Hypertensive with uncontrolled systolic blood pressure (SBP) \>135 mm Hg by unattended automated office measurement
* Currently taking 0, 1 or 2 antihypertensive medications.

Exclusion Criteria:

* Severe hypertension (SBP \> 180 mmHg or DBP \> 120 mmHg).
* Pregnant or breastfeeding.
* Known severe heart failure (LVEF \< 35%).
* Known severe valvular heart disease.
* Known pheochromocytoma.
* Known severe chronic kidney disease (CKD stage 4-5; eGFR \< 30 mL/min/1.73 m²).
* Known uncontrolled hyperthyroidism or hypothyroidism.
* Known severe diabetes (Hemoglobin A1c \> 10%).
* Known resting heart rate \> 120 bpm.
* Known persistent atrial fibrillation.
* Known Raynaud's disease.
* Known tremors or shivering disorders.
* Known exfoliative skin diseases.
* Known allergy to silicone.
* Presence of lymphedema.
* Paralysis of the arm.
* Arm amputation.
* Presence of implanted devices, such as a pacemaker, defibrillator, intravascular device, or arteriovenous fistula.
* Upper arm circumference \< 22 cm or \> 42 cm.
* Wrist circumference \> 23 cm.
* Mastectomy

Where it's running

  • Mass General Brigham Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.